CorMedix Inc. (CRMD) DCF Valuation

CorMedix Inc. (CRMD) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

CorMedix Inc. (CRMD) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Discover the true potential of CorMedix Inc. (CRMD) with our advanced DCF Calculator! Adjust essential assumptions, explore various scenarios, and evaluate how changes influence CorMedix Inc.'s (CRMD) valuation – all within a single Excel template.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .3 .2 .2 .1 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 -15.55 -20.19 -65.74 -100 -50.37 -50.37 -50.37 -50.37 -50.37
EBITDA -20.6 -27.0 -29.4 -30.1 -48.9 .0 .0 .0 .0 .0
EBITDA, % -7284 -11294.67 -15385.1 -45945.1 100 -60 -60 -60 -60 -60
Depreciation .1 .1 .2 .2 .1 .0 .0 .0 .0 .0
Depreciation, % 25.87 59.98 92.71 319.59 100 75.71 75.71 75.71 75.71 75.71
EBIT -20.7 -27.2 -29.6 -30.3 -49.0 .0 .0 .0 .0 .0
EBIT, % -7309.87 -11354.65 -15477.81 -46264.7 100 -60 -60 -60 -60 -60
Total Cash 28.5 46.5 65.7 59.0 76.0 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .1 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 0.01235588 1.4 23.76 0 100
Inventories .3 .1 .0 .0 2.1 .0 .0 .0 .0 .0
Inventories, % 119.49 60.01 1.58 0 100 52.32 52.32 52.32 52.32 52.32
Accounts Payable 1.0 1.1 2.2 2.2 4.3 .0 .0 .0 .0 .0
Accounts Payable, % 361.6 471.55 1157.22 3366.79 100 100 100 100 100 100
Capital Expenditure .0 -.1 -1.4 -.2 -.3 .0 .0 .0 .0 .0
Capital Expenditure, % -12.91 -47.08 -746.5 -335.37 100 -52 -52 -52 -52 -52
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -15.8 -22.0 -28.3 -29.7 -49.0 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -15.1 -21.7 -28.4 -29.6 -49.2 -2.2 .0 .0 .0 .0
WACC, % 11.9 11.9 11.9 11.9 11.91 11.9 11.9 11.9 11.9 11.9
PV UFCF
SUM PV UFCF -1.9
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -2
Net Debt -43
Equity Value 41
Diluted Shares Outstanding, MM 51
Equity Value Per Share 0.81

What You Will Receive

  • Comprehensive Financial Model: Leverage CorMedix Inc.’s (CRMD) actual data for accurate DCF valuation.
  • Complete Forecast Flexibility: Modify revenue growth, profit margins, WACC, and other essential metrics.
  • Real-Time Calculations: Automatic updates provide immediate feedback as you adjust inputs.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation presentations.
  • Adaptable and Reusable: Designed for versatility, allowing for repeated applications in detailed forecasting.

Key Features

  • Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for CorMedix Inc. (CRMD).
  • WACC Calculator: Pre-configured Weighted Average Cost of Capital sheet with adjustable inputs specific to CorMedix Inc. (CRMD).
  • Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates as per CorMedix Inc. (CRMD) requirements.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios relevant to CorMedix Inc. (CRMD).
  • Visual Dashboard and Charts: Graphical representations summarize essential valuation metrics for straightforward analysis of CorMedix Inc. (CRMD).

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered CorMedix Inc. (CRMD) data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for CorMedix Inc. (CRMD)’s intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for CorMedix Inc. (CRMD)?

  • Designed for Experts: A sophisticated tool tailored for analysts, investors, and healthcare consultants.
  • Accurate Data: CorMedix’s historical and projected financials are preloaded for precise analysis.
  • Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
  • Comprehensive Outputs: Instantly calculates intrinsic value, NPV, and other essential metrics.
  • User-Friendly: Step-by-step guidance ensures a smooth experience throughout the process.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling CorMedix Inc. (CRMD) stock.
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models specific to CorMedix Inc. (CRMD).
  • Consultants: Deliver professional valuation insights regarding CorMedix Inc. (CRMD) to clients quickly and accurately.
  • Business Owners: Understand how companies like CorMedix Inc. (CRMD) are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios related to CorMedix Inc. (CRMD).

What the Template Contains

  • Comprehensive DCF Model: Editable template with detailed valuation calculations specific to CorMedix Inc. (CRMD).
  • Real-World Data: CorMedix’s historical and projected financials preloaded for analysis.
  • Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to test various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for deeper insights into CorMedix Inc. (CRMD).
  • Key Ratios: Built-in analysis for profitability, efficiency, and leverage metrics relevant to CorMedix Inc. (CRMD).
  • Dashboard with Visual Outputs: Charts and tables designed for clear, actionable results tailored to CorMedix Inc. (CRMD).

No products were found matching.